James Foran

James Foran

UNVERIFIED PROFILE

Are you James Foran?   Register this Author

Register author
James Foran

James Foran

Publications by authors named "James Foran"

Are you James Foran?   Register this Author

72Publications

1866Reads

46Profile Views

Efficacy of Allogeneic Hematopoietic Cell Transplantation in Cutaneous T Cell Lymphoma: Results of a Systematic Review and Meta-Analysis.

Biol Blood Marrow Transplant 2019 Sep 5. Epub 2019 Sep 5.

Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.08.019DOI Listing
September 2019

Non-internal tandem duplication (ITD), non-tyrosine kinase domain (TKD) FLT3 mutations in myeloid malignancies: A brief report of 10 patients.

Leuk Res 2018 09 21;72:1-4. Epub 2018 Jul 21.

Division of Hematology, Mayo Clinic, Rochester MN, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.07.018DOI Listing
September 2018

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.

N Engl J Med 2018 Jun 2;378(25):2386-2398. Epub 2018 Jun 2.

From the University of Texas M.D. Anderson Cancer Center, Houston (C.D.D., H.M.K.); Memorial Sloan Kettering Cancer Center (E.M.S., M.S.T.) and Weill Cornell Medical College (G.J.R.), New York; Institut Gustave Roussy, Villejuif (S.B., C.W.), and Centre Hospitalier Universitaire Bordeaux, Bordeaux (A.P.) - both in France; Northwestern University, Chicago (J.K.A.); Ohio State University Wexner Medical Center, Columbus (A.S.M.); Sylvester Comprehensive Cancer Center, University of Miami, Miami (R.S.); University of Texas Southwestern Medical Center, Dallas (R.H.C.); University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco (G.N.M.), and City of Hope Medical Center, Duarte (A.S.S.) - both in California; University of Colorado School of Medicine, Aurora (D.A.P.); Sarah Cannon Research Institute, Nashville (W.D.); Massachusetts General Hospital Cancer Center (A.T.F.) and Dana-Farber Cancer Institute (R.M.S.), Boston, and Agios Pharmaceuticals, Cambridge (S.C., H.W., V.Z., K.E.Y., S.M.K., H.Y., D.D., B.F., M.G., H.L., S.A., B.W., E.C.A.) - all in Massachusetts; University of Alabama at Birmingham, Birmingham (H.P.E.); Johns Hopkins University, Baltimore (G.T.P.); Washington University School of Medicine, St. Louis (G.L.U.); Mayo Clinic, Jacksonville, FL (J.M.F.); Oregon Health and Science University Knight Cancer Institute, Portland (E.T.); Hollings Cancer Center, Medical University of South Carolina, Charleston (R.K.S.); Winship Cancer Institute of Emory University, Atlanta (M.L.A.); Mayo Clinic, Phoenix, AZ (J.L.S.); and Cleveland Clinic, Cleveland (M.A.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1716984DOI Listing
June 2018

Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia.

Am J Hematol 2018 02 4;93(2):213-221. Epub 2017 Dec 4.

Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24974DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586071PMC
February 2018

Do cytogenetics affect the post-remission strategy for older patients with AML in CR1?

Authors:
James M Foran

Best Pract Res Clin Haematol 2017 12 7;30(4):306-311. Epub 2017 Oct 7.

Mayo Clinic Cancer Center, 4500 San Pablo Road, Jacksonville, FL 32224, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2017.09.008DOI Listing
December 2017

Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo.

Stem Cells Transl Med 2017 03 7;6(3):840-850. Epub 2016 Nov 7.

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5966/sctm.2016-0034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442784PMC
March 2017

Older Patients With Acute Myeloid Leukemia: Treatment Challenges and Future Directions.

Ochsner J 2017 ;17(4):398-404

Division of Hematology and Oncology, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718453PMC
January 2017

Are we curing more older adults with acute myeloid leukemia with allogeneic transplantation in CR1?

Curr Opin Hematol 2016 Mar;23(2):95-101

aDivision of Hematology and Medical Oncology bMayo Clinic Cancer Center, Mayo Clinic, Jacksonville, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000220DOI Listing
March 2016

Epidemiology of adult acute myeloid leukemia: Impact of exposures on clinical phenotypes and outcomes after therapy.

Cancer Epidemiol 2015 Dec 11;39(6):1084-92. Epub 2015 Sep 11.

Division of Hematology and Medical Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2015.09.003DOI Listing
December 2015

Disseminated extranodal marginal zone lymphoma involving the gastrocnemius muscle with sural neurolymphomatosis.

Ann Hematol 2015 Nov 22;94(11):1939-40. Epub 2015 Jul 22.

Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, 4500 San Pablo Road, 32224, Jacksonville, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-015-2453-5DOI Listing
November 2015

Health Insurance-Related Disparities in Lymphoma Survival Are Partly Mediated by Baseline Clinical Factors.

Oncologist 2015 Oct 2;20(10):1223-4. Epub 2015 Oct 2.

Division of Hematology and Medical Oncology, Mayo Clinic Florida, Jacksonville, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0228DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591952PMC
October 2015

The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia.

J Hematol Oncol 2015 Oct 20;8:114. Epub 2015 Oct 20.

Division of Hematology and Medical Oncology, Mayo Clinic/Mayo Clinic Cancer Center, 13400 E. Shea Boulevard, Scottsdale, AZ, 85259, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-015-0211-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615363PMC
October 2015

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Authors:
Ayalew Tefferi Hagop Kantarjian S Vincent Rajkumar Lawrence H Baker Jan L Abkowitz John W Adamson Ranjana Hira Advani James Allison Karen H Antman Robert C Bast John M Bennett Edward J Benz Nancy Berliner Joseph Bertino Ravi Bhatia Smita Bhatia Deepa Bhojwani Charles D Blanke Clara D Bloomfield Linda Bosserman Hal E Broxmeyer John C Byrd Fernando Cabanillas George Peter Canellos Bruce A Chabner Asher Chanan-Khan Bruce Cheson Bayard Clarkson Susan L Cohn Gerardo Colon-Otero Jorge Cortes Steven Coutre Massimo Cristofanilli Walter J Curran George Q Daley Daniel J DeAngelo H Joachim Deeg Lawrence H Einhorn Harry P Erba Francisco J Esteva Elihu Estey Isaiah J Fidler James Foran Stephen Forman Emil Freireich Charles Fuchs James N George Morie A Gertz Sergio Giralt Harvey Golomb Peter Greenberg Jordan Gutterman Robert I Handin Samuel Hellman Paulo Marcelo Hoff Ronald Hoffman Waun Ki Hong Mary Horowitz Gabriel N Hortobagyi Clifford Hudis Jean Pierre Issa Bruce Evan Johnson Philip W Kantoff Kenneth Kaushansky David Khayat Fadlo R Khuri Thomas J Kipps Margaret Kripke Robert A Kyle Richard A Larson Theodore S Lawrence Ross Levine Michael P Link Scott M Lippman Sagar Lonial Gary H Lyman Maurie Markman John Mendelsohn Neal J Meropol Yoav Messinger Therese M Mulvey Susan O'Brien Roman Perez-Soler Raphael Pollock Josef Prchal Oliver Press Jerald Radich Kanti Rai Saul A Rosenberg Jacob M Rowe Hope Rugo Carolyn D Runowicz Brenda M Sandmaier Alan Saven Andrew I Schafer Charles Schiffer Mikkael A Sekeres Richard T Silver Lillian L Siu David P Steensma F Marc Stewart Wendy Stock Richard Stone Rainer Storb Louise C Strong Martin S Tallman Michael Thompson Naoto T Ueno Richard A Van Etten Julie M Vose Peter H Wiernik Eric P Winer Anas Younes Andrew D Zelenetz Charles A LeMaistre

Mayo Clin Proc 2015 Aug 23;90(8):996-1000. Epub 2015 Jul 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365030PMC
August 2015

A rare case of primary high-grade large B-cell lymphoma of the sciatic nerve.

Clin Lymphoma Myeloma Leuk 2015 Jun 11;15(6):e117-20. Epub 2014 Dec 11.

Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2014.12.001DOI Listing
June 2015

Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study.

J Clin Oncol 2015 Jan 18;33(3):251-7. Epub 2014 Aug 18.

Grzegorz S. Nowakowski, Betsy LaPlant, William R. Macon, Garth D. Nelson, Carrie A. Thompson, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansell, Thomas M. Habermann, and Thomas E. Witzig, Mayo Clinic, Rochester, MN; Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, BC, Canada; Craig B. Reeder, Mayo Clinic, Scottsdale, AZ; and James M. Foran and Candido E. Rivera, Mayo Clinic, Jacksonville, FL.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/08/14/JCO.2014.55
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.55.5714
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.55.5714DOI Listing
January 2015

Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

J Natl Cancer Inst Monogr 2014 Aug;2014(48):15-25

Department of Health Sciences Research, Mayo Clinic, Rochester, MN (JRC, SLS); Sydney School of Public Health, The University of Sydney, Sydney, Australia (AK); Department of Entomology, The Robert H. Smith Faculty of Agriculture, Koret School of Veterinary Medicine Veterinary Teaching Hospital, Hebrew University of Jerusalem, Jerusalem, Israel (OP); Winship Cancer Institute, Emory University, Atlanta, GA (CRF); Department of Cancer Etiology, Beckman Research Institute of the City of Hope, Duarte, CA (SSW, LB); Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Environmental Epidemiology of Cancer Group, F-94805, and Univ Paris Sud, UMRS 1018, F-94805, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (AB, NR, JNS, LMM); Unit of Epidemiology and Biostatistics, Centro di Riferimento Oncologico, IRCCS, Aviano, Italy (LDM); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK (EVK); Center for Chronic Immunodeficiency (CCI), University Medical Center Freiburg, Freiburg, Germany (AN); Department of Cancer Biology, Mayo Clinic Cancer Center, Jacksonville, FL (JMF); Unit of Occupational and Environmental Epidemiology, Cancer Prevention and Research Institute ISPO Florence, Florence, Italy (LM); Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL (CFS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgu010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155465PMC
August 2014

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

J Natl Cancer Inst Monogr 2014 Aug;2014(48):130-44

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (LMM, SMM, JSC, PH, NR, AB, KPC, QL, SIB, MSL, JNS); Department of Health Sciences Research (SLS, JRC, TMH), Division of Hematology (TGC), and Divison of General Internal Medicine (ML), College of Medicine, Mayo Clinic, Rochester, MN; Department of Cancer Etiology, City of Hope Beckman Research Institute, Duarte, CA (SSW, LB, AL); Prince of Wales Clinical School, University of New South Wales, Sydney, Australia (CMV); Department of Epidemiology, Comprehensive Cancer Center, University of Alabama, Birmingham, AL (CFS); Department of Epidemiology and Biostatistics, School of Medicine, University of California San Francisco, San Francisco, CA (PMB, EAH); Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Institut Català d' Oncologia, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain, CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain (SdS, YB); Unit of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden (KES); Department of Health Studies, University of Chicago, Chicago, IL (BCHC); Department of Environmental Health Sciences (YZ, TZ) and Department of Biostatistics (TRH), Yale School of Public Health, New Haven, CT; INSERM, Centre for Research in Epidemiology and Population Health (CESP), U1018, Environmental Epidemiology of Cancer Group, Villejuif, France, Univ Paris Sud, UMRS 1018, Villejuif, France (AM, JC, LO); Registry of Hematological Malignancies in Gironde, Bergonié Institute, 33076 Bordeaux, France (AM); Department of Histopathology, Douglass Hanly Moir Pathology, Macquarie Park, Australia, The Australian School of Advanced Medicine, Macquarie University, Sydney, Australia (JJT); Department of Medical Epidemiology and Biostatistics (H-OA) and Department of Oncology and Pathology (BG), Karolinska Institutet, Stockholm, Swed

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgu013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155467PMC
August 2014

Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era.

Blood 2014 Jun 4;123(23):3553-62. Epub 2014 Apr 4.

Cancer Prevention Institute of California, Fremont, CA; Division of Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2013-07-51
Publisher Site
http://dx.doi.org/10.1182/blood-2013-07-517110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047495PMC
June 2014

Frontline therapy of AML: should the older patient be treated differently?

Authors:
James M Foran

Curr Hematol Malig Rep 2014 Jun;9(2):100-8

Mayo Clinic Cancer Center, Division of Hematology & Medical Oncology, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL, 32224, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11899-014-0211-8
Publisher Site
http://dx.doi.org/10.1007/s11899-014-0211-8DOI Listing
June 2014

The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs.

Br J Haematol 2014 Apr 27;165(1):78-88. Epub 2014 Jan 27.

Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12731DOI Listing
April 2014

Phase I study of quizartinib administered daily to patients with relapsed or refractory acute myeloid leukemia irrespective of FMS-like tyrosine kinase 3-internal tandem duplication status.

J Clin Oncol 2013 Oct 3;31(29):3681-7. Epub 2013 Sep 3.

Jorge E. Cortes, Hagop Kantarjian, and Gautam Borthakur, the University of Texas, MD Anderson Cancer Center, Houston, TX; James M. Foran, University of Alabama at Birmingham, Birmingham, AL; Darejan Ghirdaladze, Medulla-Chemotherapy and Immunotherapy Clinic; Mamia Zodelava, Hema-Hematology and Chemotherapy Clinic, T'bilisi, GA; Guy Gammon, Denise Trone, Robert C. Armstrong, and Joyce James, Ambit Biosciences, San Diego, CA; and Mark Levis, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.48.8783DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804291PMC
October 2013

Rituximab use and survival after diffuse large B-cell or follicular lymphoma: a population-based study.

Leuk Lymphoma 2013 Apr 28;54(4):743-51. Epub 2012 Sep 28.

Cancer Prevention Institute of California, Fremont, CA 94538, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.727415DOI Listing
April 2013

Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes.

Am J Med 2012 Jul;125(7 Suppl):S6-13

Mayo Clinic, Jacksonville, Florida 32224, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S000293431200339
Publisher Site
http://dx.doi.org/10.1016/j.amjmed.2012.04.015DOI Listing
July 2012

Gemtuzumab: time to bring back on the market?

Authors:
James M Foran

Clin Adv Hematol Oncol 2012 May;10(5):326-7

Division of Hematology & Medical Oncology, Mayo Clinic Cancer Center, Jacksonville, Florida.

View Article

Download full-text PDF

Source
May 2012

Targeted therapy of acute myeloid leukemia in 2012: towards individualized therapy.

Authors:
James M Foran

Hematology 2012 Apr;17 Suppl 1:S137-40

Department of Internal Medicine, Division of Hematology/Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1179/102453312X13336169156456DOI Listing
April 2012

A case of acute promyelocytic leukemia without RARα rearrangement and apparently normal cytogenetics.

Clin Lymphoma Myeloma Leuk 2011 Dec 19;11(6):521-4. Epub 2011 May 19.

Division of Hematology and Oncology, University of Alabama at Birmingham, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2011.03.036DOI Listing
December 2011

New prognostic markers in acute myeloid leukemia: perspective from the clinic.

Authors:
James M Foran

Hematology Am Soc Hematol Educ Program 2010 ;2010:47-55

Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2010.1.47DOI Listing
April 2011

Hepatitis C in the rituximab era.

Authors:
James M Foran

Blood 2010 Dec;116(24):5081-2

University of Alabama at Birmingham, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-09-307827DOI Listing
December 2010

Successful treatment of T-cell prolymphocytic leukemia with full-intensity conditioning followed by matched unrelated donor allogeneic stem cell transplantation.

Clin Adv Hematol Oncol 2007 Nov;5(11):882-4; discussion 884

Hematology/Oncology and Bone Marrow Transplantation, University of Alabama at Birmingham, Birmingham, AL 35249, USA.

View Article

Download full-text PDF

Source
November 2007

Antibody-based therapy of non-Hodgkin's lymphoma.

Authors:
James M Foran

Best Pract Res Clin Haematol 2002 Sep;15(3):449-65

Department of Internal Medicine, University of Nebraska Medical Center, Lied Transplant Center, Emile at 42nd Street, Omaha, Nebraska 68198, USA.

View Article

Download full-text PDF

Source
September 2002